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Abstract
Subtelomeric regions are often under-represented in genome sequences of eukaryotes. One of the best known examples of the
use of telomere proximity for adaptive purposes are the bloodstream expression sites (BESs) of the African trypanosome
Trypanosoma brucei. To enhance our understanding of BES structure and function in host adaptation and immune evasion, the
BES repertoire from the Lister 427 strain of T. brucei were independently tagged and sequenced. BESs are polymorphic in size
and structure but reveal a surprisingly conserved architecture in the context of extensive recombination. Very small BESs do
exist and many functioning BESs do not contain the full complement of expression site associated genes (ESAGs). The
consequences of duplicated or missing ESAGs, including ESAG9, a newly named ESAG12, and additional variant surface
glycoprotein genes (VSGs) were evaluated by functional assays after BESs were tagged with a drug-resistance gene.
Phylogenetic analysis of constituent ESAG families suggests that BESs are sequence mosaics and that extensive recombination
has shaped the evolution of the BES repertoire. This work opens important perspectives in understanding the molecular
mechanisms of antigenic variation, a widely used strategy for immune evasion in pathogens, and telomere biology.
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Introduction
Subtelomeres are dynamic and fast-evolving regions of eukaryotic
genomes owing to their remarkable plasticity [1–3]. Recombination
between internal repeats and chromosomal arms results in the
accumulation of species-specific sequences, commonly mediating
adaptation to the environment. Despite their extreme genetic
diversity, common aspects of structure and function are shared
across telomeres from a diverse range of organisms [4].
The ability to encode contingency functions within their
subtelomeric regions has been exploited by the African Trypano-
some, subspecies of which cause the debilitating disease Human
African Trypanosomiasis and the related disease ‘nagana’ in
livestock [reviewed in [2]. Trypanosoma brucei evades the mamma-
lian host’s immune response by periodically changing its variant
surface glycoprotein (VSG) coat (reviewed in: [5]), a dense
monolayer of 56106 identical VSG dimers. The expressed VSG
is located in specialised subtelomeric transcription units known as
the Bloodstream Expression Sites (BES). The total number of
BESs is dependent on the subspecies and strain but is believed to
be about 20 for the T. brucei Lister 427 strain [6] used in the
present study. To change the VSG coat, transcription is switched
to an alternative VSG by recombination of a new VSG into the
active BES or by transcriptional silencing of one BES with
concomitant activation of a second.
Sequencing of a few BESs has revealed a diverse range of 11
polymorphic genes, called Expression Site Associated Genes
(ESAGs) [7], few of which have been functionally characterised:
ESAG3, ESAG5 and ESAG11 encode membrane-associated or
membrane-targeted proteins [8]; ESAG4 encodes a putative
transmembrane receptor with adenylate cyclase activity [9];
ESAG6 and ESAG7 encode subunits of a heterodimeric receptor
that mediates uptake of host transferrin [10,11]; ESAG8 encodes a
putative nuclear DNA-binding protein [12,13]; ESAG10 encodes a
homologue of the Leishmania biopterin transporter [14] whilst
ESAG9 [15] has an unknown function. As many ESAGs are
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members of large families and are dispersed in the genome [16–
18], and as a low level of transcription occurs even from ‘inactive’
BESs, determining the precise function of individual ESAGs in
active expression sites is challenging.
In an effort to systematically analyse the BES repertoire of a single
clone, a library of transformation-associated recombination (TAR)
clones was made [19]. In the present study, sequence analysis
revealed that the 19 TAR clones fall into 14 distinct BES groups.
Independently, 13 randomly tagged BESs were constructed and
analyzed, confirming the structures and re-defining the minimal
gene complement of a functional BES for survival in culture.
Patterns of sequence variation between different ESAG families
were analysed revealing that expression sites are sequence mosaics
- related to each other differently depending on the gene family
examined - and highlighting the significant role that recombina-
tion between gene families has played in forming BES sequences.
In characterising a complete BES repertoire these results provide a
perspective on nucleotide diversity, but also on the mechanisms
regulating their origins and diversity.
Results
Two independent approaches were undertaken. First, BESs were
randomly tagged with a G418-resistance gene, and we will refer to
these clones as ‘NEO-tagged’. Second, TAR-cloned BESs were
sequenced, and we will refer to these clones either by their TAR
clone number or by the BES to which they have been assigned.
Tagging BESs
T. brucei cell lines tagged with two drug-resistance markers were
generated to select parasites that had stochastically activated an
individually tagged BES from the background of highly similar
BESs. The active BES1 was tagged with a Puromycin resistance
gene (PUR), immediately downstream of the promoter. In the
remaining silent BESs, transcription initiates at the BES promoter
but is rapidly attenuated. This low level of transcriptional activity
allowed the integration of a Neomycin resistance gene (NEO)
immediately downstream of a second ‘silent’ BES promoter. In this
way, we obtained 30 double-tagged clones. Each randomly NEO-
tagged BES was typed according to its ESAG6 hypervariable
region, the distance between the ESAG6 gene and the promoter,
the number of BES promoters, and the sequence of the expressed
VSG upon BES activation. Analysis of the 30 NEO-tagged clones
and comparison to the TAR clones showed that 13 different BESs
were tagged: BES1, 2, 3, 4, 5, 7, 8, 12, 13, 14, 15a and 15b (a
duplicated BES, see below) and 17 (Tables 1 and 2). All tagged
BES could be activated in vitro, except for BES8. Characterisation
of these clones confirmed many of the apparently anomalous
structures revealed by the TAR sequences (see below). The only
two cloned BESs that were not tagged were BES10 and BES11
(Tables 1 and 2).
Chromosomal localization of BESs
The chromosome containing each BES (indicated by arrows in
Figure 1) was identified by Southern blotting of PFGE-separated
chromosomal DNA with NEO and VSG probes (Figure 1). It had
been shown previously that BES2 is located on an intermediate
chromosome [20]. We now show that BES4, BES10, BES11,
BES13 and BES17 are also present in this chromosome class and
that the megabase-sized chromosomes encode all remaining BES,
consistent with previous reports [21].
In some cases, the VSG probe hybridized with more than one
chromosome, indicating that the genome contains multiple copies
of the corresponding VSG. For instance, BES12 and BES14
contain VSG427-8, and BES15a and BES15b contain VSGbR-2/
427-11, on megabase chromosomes of different sizes (Figures S1A
and S1B, respectively). VSG121/427-6 is present as a non-BES
copy (Dreesen O., personal communication).
Switching mechanism and frequency
The switching assay was designed to select for trypanosomes that
had undergone an in situ switch by transcriptionally silencing BES1
and activating another BES without any DNA rearrangements. To
assess the efficiency of selecting in situ switchers, Puromycin- and
G418-resistant clones were analyzed by PFGE. If an in situ switch
had occurred, the chromosomal locations of PUR, NEO and VSG
should be unchanged: PUR and VSG221/427-2 should be on
chromosomeVIa, whereasNEO and the newly identified VSG should
be located on a different chromosome. PFGE analysis of 28 NEO-
tagged clones that had activated different BES (2, 4, 5, 7, 13, 14, 15b
and 17) confirmed that in situ switching was the predominant
switching mechanism (15 switch events), but other switching
mechanisms were also observed (Figure 2). In BES2- or BES15-
tagged clones, for example, we observed that VSG221/427-2 and
PUR were deleted, whereas NEO and the new VSG remained in their
original chromosomal location. This suggests that activation of BES5
and BES15 was accompanied by the truncation of BES1, a
phenomenon previously reported for another BES [22]. In three
of the 28 cases studied, the active BES was replaced by duplicative
transposition of the entire new BES. In switchers that activated BES7
(Figure 2B), BES13 or BES15b, VSG221/427-2 and PUR were lost
and NEO and the new VSG genes were duplicated onto chromosome
VIa. This switching mechanism has been previously detected in
switchers obtained in mice [23] or by negative-selection in vitro [24].
In three cases, we observed unconventional recombination events
that involved more than two chromosomes. These complicated VSG
switch events that have undergone multiple DNA rearrangements
have been previously documented [25].
In our cell-lines, the frequency of switching between BES1 and a
second BES can be measured as the ratio between the number of
G418-resistant clones and the total number of starting cells.
Switching frequency was measured for clones in which the NEO
gene was in BES4, 5, 13, 15b and 17. Consistent with previous
reports, the average frequency was around 26361026 switchers/
cell, with BES15 showing the lowest switching frequency
(8.361028 switchers/cell) [20,26]. However, it should be noted
that these measurements were based on a small number of
independent clones (usually 3). A larger-scale study would be
necessary to assess if the differences of switching frequency are
statistically significant and how those correlate with the DNA
sequence of the activated BES.
Sequencing and assembly of TAR clones
Nineteen TAR clones [19] were sequenced, manually finished
and analysed. This set represents 14 unique BESs, with TAR
clones from BESs 9 and 16 having been re-classified (Table 2). For
each BES group, at least one clone was sequenced (Figure 3,
Table 1), choosing a larger sized clone wherever possible.
Additional clones were sequenced for BES3 and BES4 to verify
the sequence and clone integrity. Global alignments showed that
TAR clones 2 and 15 (BES3) as well as 3 and 28 (BES4) are 100%
identical at the DNA level with the exception of an ESAG7
triplication in TAR28. In addition, TAR clones from BES1
(TAR40), BES2 (TAR129) and BES17 (TAR59) were compared
to the same BES previously sequenced from a BAC library [27]
and were 99%,100% and 99% identical, respectively, indicating
that TAR cloning produced stable clones.
Architecture of T. brucei BESs
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BES architecture
Eighteen of the TAR clones contain full-length BESs, ending in
telomeric hexamer repeats, and the 14 BES types show a striking
conservation in overall structure and order of ESAGs (Figure 3).
The 59 end of each TAR clone contains the BES promoter that
was used as the recombination target during cloning. Half of the
BESs have a second promoter approximately 13 kb upstream from
the first [28] which accounts for the differences in clone sizes
observed in some of the BES groups. The region between the two
promoters encodes ESAG10 and a variety of pseudogenes that are
commonly found in T. brucei subtelomeric regions (Figure 3). The
presence of two promoters in some BES was confirmed by
restriction mapping of the NEO-tagged clones. BES5 and BES8
were the only two discrepancies: NEO-tagged clones suggested the
presence of 2 promoters, whereas TAR clones only had one,
presumably because the downstream promoter was the target of
the TAR cloning (Figure S3B). Downstream of the second
promoter, the majority of sites encode polymorphic variants of
ESAG7, ESAG6, ESAG5, ESAG3, ESAG4, ESAG8, ESAG3, ESAG2,
ESAG11 and ESAG1, in this conserved order. The only exception
was an inversion between ESAG7 and ESAG6 in two BES groups
(TAR29/BES12 and TAR56/BES13).
Nine BESs encode at least one copy of each ESAG (excluding
ESAG10). We also observed frequent duplication of ESAGs,
including a large-scale duplication in BES1 (TAR40), an ESAG7
triplication in BES4/TAR28 and three cases of divergent
additional copies of ESAG8 (BES1, BES13 and BES15).
The terminal VSGs are flanked upstream by tracts of 70-bp
repeats, whose lengths vary in our assemblies between 0.2–7.1 kb,
although this repeat region was only manually finished in 10
clones (Figure 3). The distance between the VSG and the telomeric
repeats could be assessed in 17 TAR clones and ranged from 200–
1590 nucleotides.
As described above, the analysis of the NEO-tagged clones
was consistent with the analysis of TAR clones except in one
case. Although VSG221/427-2 is a single-copy gene (Figure 1),
we found it in both BES1/TAR40 and BES16/TAR128. The
presence of VSG221/427-2 in BES1 has been firmly estab-
lished from sequencing one BAC and two TAR clones. The
promoter-proximal region (approx 40 kb) of TAR128 is
identical to TAR126. Taken this data together, we conclude
that TAR128 may be an artefact that resulted from
recombination between BES1 and BES15. PCR analysis of
additional TAR clones of BES16 failed to detect VSG221/427-
Table 2. Summary of the number of TAR clones sequenced, BES identified and BES activated.
Number TAR clones or BES TAR clones or BES missing
TAR clones 19 40, 129, 2, 15, 3, 28, 98, 65, 153, 64, 134, 122, 29, 56, 10, 126, 128, 51, 59 TAR128 is probably a recombination artifact
Unique BES 14 1, 2, 3, 4, 5, 7, 8, 10, 11, 12, 13, 14, 15, 17 TAR2 and TAR3 were duplicates of TAR15 and TAR28,
respectively; TAR51 and TAR65 were re-classified
All BES 15 1, 2, 3, 4, 5, 7, 8, 10, 11, 12, 13, 14, 15a+15b, 17 BES15 is present in two copies in the genome
Tagged BES 13 1, 2, 3, 4, 5, 7, 8, 12, 13, 14, 15a+15b, 17 BES10 and BES11 were not tagged
Functional tagged BES 12 1, 2, 3, 4, 5, 7, 12, 13, 14, 15a+15b, 17 BES8 was tagged with NEO gene, but no G418-
resistant clones could be obtained.
doi:10.1371/journal.pone.0003527.t002
Figure 1. Chromosomal distribution of BES-resident VSGs. Red arrows indicate BES randomly tagged in this study with NEO. Open arrows
indicate BES activated by [58] and subsequently tagged. Names of VSG genes are indicated at the bottom, using the newly proposed strain-specific
numbering (top row) and lab-specific names (bottom row). BES10 and 11 were not tagged in either study. BES14 is represented in two lanes: 14*
refers to TAR117 (which was not sequenced and harbours VSG8), whereas 14$ refers to TAR10 (which was sequenced and harbours VSG9).
doi:10.1371/journal.pone.0003527.g001
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2 (data not shown), further suggesting that TAR128 is not
representative of BES16.
Non-functional and novel BES genes
A defining feature shared by most BESs is the strict conservation
of the 59 copy of ESAG3 and ESAG11 as pseudogenes (Figure 3). The
predominance of the latter is corroborated by a previous study
describing the characterisation of this gene family [7]. In addition to
these two pseudogenes, single frameshifts cause the presumed
inactivation of ESAG4 and ESAG5 in some BESs. An analysis of
ESAG processing signals gave further indication that some of the
ESAGsmay not localise correctly within the cell, including a number
of ESAG4 genes which lack sequences for surface targeting.
In five BESs (BESs 1, 2, 4, 5, 7) we identified a novel highly
conserved putative protein coding sequence with a predicted signal
peptide that we have designated ESAG12 (Figure 3). No functional
clues could be discerned from sequence similarity or protein
domain search results. A single homologue is found in the TREU
927 genome (Tb927.7.7510), although this is likely to be an under-
representation due to the lack of subtelomeric sequence in the
current TREU 927 genome assembly [18].
Some BES deviate from the overall conserved structure
Several BESs diverge from this conserved structure either by
encoding additional sequences or because they represent truncated
sites, lacking members of individual ESAG families. Most BES
harbour only the VSG between the 70 bp-repeat array and the
telomere (Figure 3). BESs 2, 4, 7 and 15 are exceptions to this rule,
showing additional sequences (ingi element, VSG or ESAG3
pseudogene). A further three sites encode duplicated regions of
70-bp repeats (BES1, 14 and 15), in each instance sandwiching
VSG pseudogenes (see below). Five of the BES groups do not
contain one or more of the expected ESAG repertoire. Amongst
this set are:
BES7 (TARs 65,153) lacks ESAG7, but contains tandem copies
of ESAG6, with different hypervariable regions, with ESAG6a
resembling an ESAG6/ESAG7 mosaic. This BES could be
activated in vitro at the same frequency as other BESs. In order
to investigate whether any DNA rearrangements have donated a
copy of ESAG7 to the newly activated BES7, DNA from cells with
an active or silent BES7 were compared by PCR and restriction
mapping (Figure S2). No differences were observed, suggesting
that a BES lacking ESAG7 can indeed be activated, confirming
previous observations [29].
BES8 (TAR64) is unusually small and only contains a single
copy of ESAG7 followed by the 70-bp repeat region and the VSG
(Figure 3). Long-range analysis of chromosomal DNA from a
BES8-tagged clone digested with Apa I supported this finding, with
the NEO and VSG427-14-hybridizing restriction fragment being
only ,20 kb in length (Figure S3A). Genotyping of the NEO-
tagged clone confirmed the presence of ESAG7 and absence of
ESAG6 (data not shown). Attempts to activate this BES in two
independent clones were unsuccessful, suggesting that this mini-
BES may not be functional.
BES10 (TAR134) lacks the central portion (ESAG 4-8-3-2-11-1).
TAR134 also encodes only a 23-bp fraction of a 70-bp repeat.
This site was not among those that were tagged with a drug
resistance marker, so its potential for activation could not be
assessed.
BES14 (TAR10), also lacks the ESAG4-8-3 gene cluster and has
two VSG pseudogenes sandwiched between 70-bp repeat arrays.
An inconsistency was found between the NEO-tagged clone and
TAR sequence. The NEO-tagged clone did not harbour the VSG
predicted by the TAR clone. Instead, the NEO tagged cell line
expressed VSG427-8 upon activation, rather than VSG427-19, as
predicted by the TAR sequence. We confirmed by PFGE that the
BES activation did not involve gene rearrangements (data not
shown), indicating that VSG427-8 was at the BES14 locus prior to
activation. Further examination of the TAR clones in the BES14
set revealed TAR117 to correspond to the NEO-tagged clone. An
interesting consequence of these results is that two BESs (BES12
and BES14) contain the VSG427-8 gene (Figures 1 and S1A).
In BES11 (TAR122), the ESAG2-11-1 cluster has been replaced
by a VSG-related gene (VR, Figure 3) and a full-length copy of
ESAG9, the only copy found to date in a T. brucei BES. The VR
gene is believed to be a VSG that has already evolved a new
function and, like other VRs, has no 70-bp repeat sequences in its
Figure 2. Types of switching mechanisms observed for tagged
BES clones in vitro. A. NEO-tagged clones have PUR in BES1 and NEO
in an unknown BES. B. Example of a BES duplication. PFGE analysis of a
BES7-tagged clone (17.9), when this BES is silent (S) and after activation.
NEO and VSG3 genes were duplicated onto the chromosome that
originally contained PUR and VSG221/427-2. C. Quantification of the
frequency of the different types of mechanisms. ‘‘Other’’ refers to
recombination events that involved more than 2 chromosomes.
doi:10.1371/journal.pone.0003527.g002
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Figure 3. Overview of T. brucei Lister 427 BES. BES are drawn to scale and have been aligned at their 59-most ESAG7 or ESAG6 sequence. The
inset shows the regions conserved between the dual promoters present in some of the clones. The VSG indicated in front of the BES label refers to
the telomere-proximal VSG.
doi:10.1371/journal.pone.0003527.g003
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upstream flank [30]. Similarly to BES10, this site was not tagged
with a drug selectable marker and therefore, activation in vitro
could not be assessed.
BES12 (TAR29) has a deletion of the ESAG4-8-3 cluster, but
successful tagging and activation demonstrated that this site was
functional in vitro (Table 1).
Investigating the forces driving BES diversity
In order to investigate the role of recombination in the evolution
of bloodstream expressions sites, we examined changes in
phylogenetic relationships along the BESs using two methods.
Likelihood comparisons of optimal and constrained
trees. There were obvious discrepancies between the optimal
phylogenies for different ESAG loci, suggesting that the
phylogenetic signal varied along the BESs. This was manifest in
both the different shapes of ESAG trees and comparisons of their
log-likelihood scores (Figures 4 and S4). Comparing the likelihood
score of an optimal topology for any given ESAG with the score
obtained for a tree constrained with the signal of another ESAG
locus, typically indicated a decrease in likelihood and therefore a
decreased probability of shared histories. Indeed, the drop in
likelihood was generally proportional with physical distance, such
that topologies from different ends of the expression sites were
most dissimilar (Figures 4 and S4). Although topological
differences between the phylogenies of neighbouring ESAGs were
observed, these were non-significant and fell within the margins of
systematic error. In fact, comparisons for all genes (Figure S4)
showed that ESAGs fell into three clusters with regard to
phylogenetic signal: ESAGs 7, 6 and 5, ESAGs 4 and 8, and
ESAGs 2, 1 and 11 with compatible phylogenetic signals within,
but not between, these clusters.
Recombination analyses. To examine the fine scale
structure of recombination within the BESs, a genetic algorithm-
based tool (GARD) [31] was used to infer the numbers and
locations of recombination breakpoints. Although this method
relies on phylogenetic incompatibility to deduce recombination,
GARD differs from the constrained tree analyses described above
in two important respects: (i) the locations of putative breakpoints
are inferred rather than fixed a priori, allowing us to characterize
recombination within individual loci, and (ii) GARD is able to
detect gene conversion events that affect branch lengths but not
tree topology. When applied to the nucleotide alignments of each
ESAG locus and to five intergenic regions, this method identified a
large number of recombination tracts with distinct phylogenetic
histories (Tables S1 and S2). Mean recombination tract lengths
ranged from 90 bp/tract for ESAG1 to 687 bp/tract for ESAG10,
Figure 4. Quantifying the difference in phylogenetic signal along the bloodstream expression site. A. Three tanglegrams relate the
ESAG5 phylogeny with those of ESAG6 (close match), ESAG4 (moderate incongruence) and ESAG1 (severe incongruence). Dashed lines link
corresponding expression sites in each tree. Incongruence between trees increases from left to right. B. Comparison of likelihood scores between
optimal and constrained tree topologies for ESAG5. The phylogenies of six other ESAG loci (indicated by a cartoon of the expression site) were used to
constrain the estimation of the ESAG5 tree; the difference in likelihood score between each of these constrained trees and the optimal ESAG5 tree is
plotted along the expression site. Non-significant differences in likelihood are denoted by a dashed circle as evident when constraining the ESAG5
topology with the ESAG6 topology; however, enforcing the topologies of central loci (ESAGs 4 and 8) caused a moderate decrease in likelihood, whilst
constraining with ESAGs 2, 11 or 1 caused a larger decrease.
doi:10.1371/journal.pone.0003527.g004
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and mean tract lengths were similar in both coding and non-
coding sequences. The GARD analyses demonstrate that
phylogenetic breakpoints occur throughout the expression sites,
consistent with frequent genetic exchange.
Phylogenetic inference of recombination can be misled by
substitution rate variation, as could occur if different genes or
regions within a gene are subject to different selection pressures.
Therefore, a summary statistic-based approach, the Pairwise
Homoplasy Index (W) Test [32], which has been shown to be
robust to substitution rate variation, was applied to each alignment
to validate the GARD analyses, and to each of the individual
recombination tracts inferred by GARD to identify any further
recombination that might exist. With the exception of ESAG10,
which is highly conserved, significant values of W were obtained for
each ESAG alignment, consistent with recombination within these
loci (Table S2). In addition, the W values were significant in at least
some of the GARD-inferred tracts within all ESAG loci except
ESAG8 and ESAG10, and in 30% of individual tracts overall.
These results indicate that there are additional breakpoints not
detected by GARD, and support the conclusion that there is
extensive recombination throughout the entire BES.
Evidence of molecular adaptation within ESAG
families. The role of selection in the evolution of bloodstream
expression sites was examined by estimating the ratio of the non-
synonymous and synonymous substitution rates (v) within each
ESAG family. A likelihood ratio test was used to assess whether the
distribution of v across codons is best explained by a model (M1a)
which assumes that all sites are evolving neutrally or under purifying
selection, or by a model (M2a) which includes an additional category
of sites under positive selection (i.e.,v.1). As indicated by the higher
likelihood scores of model M2a (Table S3), these tests provide
significant evidence of adaptive evolution within ESAGs 4, 5, 6, and
7, and are nearly significant (p,0.1) for ESAG1 and ESAG3b. In
contrast, there is no evidence of adaptive evolution in ESAGs 2, 8 and
10. Selective pressures at individual codons were inferred using a
Bayesian approach with model M2a used as a prior distribution on
v. As expected, the majority of sites appear to be subject to strong
purifying selection (v%0.5), while the numbers of positively-selected
sites corroborate the gene-wide analyses, with ESAGs 4–7 displaying
widespread adaptation (Table S4). Taken together, these results
indicate that all ESAGs are under strong purifying selection,
presumably to maintain functionality, and that most ESAGs
contain at least some sites which have undergone adaptive
evolution over the course of BES differentiation.
Discussion
The elucidation of the BES repertoire of a single T. brucei strain
has produced a global view of BES structure and evolution. We
have sequenced 19 out of 182 clones of BESs from T. brucei 427,
chosen to represent as many different BESs as possible based on
the preliminary analysis of the original set [19] and including
duplicates. Sequence analysis identified 14 distinct BESs, one of
which exists in two copies, giving a total number of 15 BESs. Have
we found all of the BESs in T. brucei 427? Assuming that the
promoter sequence is conserved in all BESs, we estimated the
chance of missing any BESs in the entire library by simulating
samples of 182 randomly sampled clones from populations with
different numbers of underlying BESs. In such a simulation, no
sites are ‘missed’ if there were 19 or fewer BESs. Based on all of the
available data the subset chosen for sequencing appears to cover
most, if not all, BESs. Thirteen of these 15 BES were tagged with
the Neomycin resistance gene in 30 random integration events.
Assuming equal probability of tagging any end we expect to miss
at least 2 out of 15 BESs in 30 tagging events 65% of the time
(simulation of 1000 random samples of 30 tagging events). No
BESs were tagged that were absent from the collection of TAR
clones and we therefore are confident that the library contains the
entire T. brucei Lister 427 BES repertoire. We will however only be
able to address the question as to whether the size of the BES
repertoire of T. brucei Lister 427 is shared by other Trypanosoma
brucei isolates once a large number of strains are analyzed. The
genome strain T. brucei TREU 927 has fewer BESs based on
hybridization analysis [33] and a similar set of T. brucei 927 BES
TAR clones with only 5–8 promoter and ESAG6 region sequence
types have been identified (Becker and Louis, unpublished). In
addition to having fewer BESs, T. brucei 927 also has smaller VSG
basic copy arrays compared with T. brucei 427, though the genome
strain T. brucei TREU 927 has one of the smallest genomes
analysed among T. brucei isolates [34]. This makes it likely that the
relatively large number of BESs that we observe here with T. brucei
427 does indeed fall within the range of BES copy numbers that
may be observed among different isolates.
The validity of the TAR cloning is demonstrated by the
identical sequences obtained from two independent TAR clones of
the same BES, by the comparison to previously published
sequences and by the congruence with the data obtained from
the NEO-tagged BES. Given both the number of TAR clones
from known BESs and TAR cloned DNA that does not exist in the
genome, we get a maximum estimate of 15% of aberrant TAR
clones in the original library. In fact, only one of the 19 TAR
clones selected for sequencing (TAR128) is inconsistent with other
data and could be a recombinant between two BESs generated
during TAR cloning. The other clones originally classified with
this clone in BES group 16 appear not to be recombinant and
could be sequenced in the future.
The sequencing effort has also highlighted the need to return to
the original TAR clone set to account for misclassifications based
on the hypervariable region of ESAG6 and the promoter sequence.
Given that the promoter sequence was the target for recombina-
tion, the actual cloning procedure may have introduced variability
in this region not present in the genome. As a consequence, two
TAR clones were re-assigned in this study to different BES groups,
giving fewer groupings than the original classification into 19
groups. It is clear that correct and complete characterisation of the
telomeres requires a combination of saturation cloning and
sequencing of well-chosen clones.
Characterisation of parasites with activated NEO-tagged BESs
revealed that, as expected, in situ switching was the most frequent
event. Interestingly, in three out of 28 switchers, we observed a
switching mechanism, in which the previously active BES (BES1)
was replaced by a duplication of the newly activated BES (7, 13 or
15b). Most likely recombination between the two subtelomeric
regions occurs upstream of the drug-resistance genes, possibly at the
promoter region, the 50 bp-repeat array, or in an even more internal
chromosomal location. It is unclear which of the two BES copies is
the active one. Nevertheless, our observations confirm what has been
previously reported that an entire BES can be duplicated and
transposed to a different locus [23,24], which is reminiscent of break-
induced replication in yeast. In fact, when a double-strand break is
induced in subtelomeric regions of S. cerevisiae, that end is often
replaced by a duplicated copy of another end (reviewed in [35]).
Such mechanism could explain the existence of two copies of BES15
and it may also have contributed to the large number of BES in T.
brucei 427 relative to other isolates.
The BESs presented here show considerable diversity in the
ESAG complement, though there is an overall conservation of
order that agrees with the generic BES structure previously
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proposed [27] (top diagram in Figure 3). There are some clear
exceptions within the overall conservation, ranging from a small
BES containing only ESAG7 and a VSG, to a BES containing ESAG
duplications and triplications. The BES-tagging data presented
here redefine the requirement for a minimal BES, which appears
only to entail functional copies of ESAGs 1, 2 and 6, although
ESAG1 is not essential within an active BES [16,17] and ESAG2 is
absent from the BES encoding SRA, the T. b. rhodesiense gene able
to confer resistance to human serum in infections [36]. There
appears to be no requirement for ESAG7, as previously postulated
[27]. The smallest BES we came across as part of this study only
encodes ESAG7 in addition to VSG (BES8). We were unfortunately
unable to show activation of this site in vitro but it may yet indicate
that none of the ESAGs need to be expressed from the active BES.
However, the absolute requirement of ESAGs in an expression site
is difficult to test because low-level transcription of ESAG6 and
ESAG7 and indeed other ESAGs may occur from ‘silent’ sites
[37,38]. Even if these truncated BES are not functional, they may
still contribute sequences via gene conversion to other BESs.
One surprising finding was the presence of additional sequences
downstream of the 70-bp repeat in some BESs, as well as the
number of BESs containing additional VSG pseudogenes. The
presence of pseudogenes towards the downstream end of the BES
is not entirely unexpected though, as this area is a recombinational
hotspot, continually accepting incoming copies of VSG cassettes in
order to mediate antigenic variation. As the recombination
processes involved may not be constrained by the high stringency
normally imposed by mismatch repair [39], it has to be expected
that there will be errors, such as a duplicated cassette being copied
into another cassette, rather than replacing it. Most of the VSGs in
the silent archive are full-length pseudogenes, at least some of
which contribute ‘healthy’ sequence to novel mosaic expressed
VSGs [30]. It has been speculated that silent BESs might safely
foster the stepwise assembly of mosaics, in contrast to the active
BES, from which there is an absolute requirement for expression
of an intact VSG [40,41]. The present findings are compatible with
this proposal, but not conclusive. The VSG pseudogenes could be
copies of silent VSG pseudogenes, or partially assembled mosaics,
or genes that have degenerated in situ through lack of requirement
for expression. Work is underway to address the question of
mosaic VSG assembly and expression.
The repertoire of BESs gives some indication of their
proliferation among telomeres and their macroevolution. The
driving forces that have shaped this repertoire are segmental
duplications and deletions, recombination events typical of
subtelomeres. However, gene content does not always coincide
with the relationships among ESAG genes; for instance, BES13,
15 and 16 all possess a tandem duplication of ESAG8, but are not
closely related based on their ESAG8 nucleotide sequences. The
incongruence between gene trees for the different ESAGs confirms
that BESs have not diversified through ‘orthodox’ patterns of
duplication and divergence. Rather, each BES is a mosaic and the
product of frequent recombination between telomeres; this may
occur through reciprocal crossover events between homologous
strands at mitosis, or through non-reciprocal gene conversion.
Recombination is frequently non-homologous, as we observe both
segmental deletions and duplications, (for instance the substantial
duplications and triplications within BES1), and variations in
length, with some BESs greatly reduced in size (e.g. BES8 and
BES10).
This process is consistent with previous observations of
‘telomere exchange’ [42], though the prevalence of mosaics
demonstrates that whole telomeres are not typically exchanged.
Instead, the data suggest that clusters of contiguous ESAGs share
common histories, and therefore have not frequently been split by
recombination. There appears to be a physical limit on the
frequency of recombination breakpoints, which seldom occur in
between ESAGs 7, 6 and 5, ESAGs 4 and 8 or between ESAGs2, 1
and 11 (Figure 4, Table S2). However, the transposition of an
isolated ESAG7 copy into an active expression site (without
ESAG6 and 5) has been reported under in vitro drug and serum
selection pressure [38]. This provides experimental evidence that
ESAGs can and do move between sites, with the loss of a particular
allele from the active BES; our data qualify this by showing that
ESAG7 usually transpose in unison with ESAGs6 and 5 (otherwise
they would not share a common phylogenetic history).
Given that frequent breakpoints coincide with the position of
ESAG3 loci between linkage blocks, these could play a role in
orientating expression sites prior to the exchange of intervening
regions. This could also explain why ESAG3a, b and c sequences do
not cluster by position (data not shown). It is therefore conceivable
that the conserved, repetitive, higher order structure of expression
sites may be maintained as a template for recombination, either to
enhance the function of ESAGs, or of the VSG switching
mechanism. Alternatively, the overall structure could be a
secondary, non-adaptive result of the VSG switching events.
The majority of ESAGs within expression sites are unusual in
that they are part of larger gene families present at chromosome
internal locations within the genome but ‘behave’ like a tandem
gene array or highly linked loci [43]. Internal and telomeric gene
copies seem to evolve in very different ways. Internal copies of
some families, for example ESAG4 and 5 are more diverse and
retain orthology with corresponding loci in the related species.
Telomeric ESAG copies in contrast have relatively low levels of
variation and therefore always form a clade in ESAG family
phylogenies (data not shown). This indicates that frequent
recombination between telomeric copies leads to homogenisation
and concerted evolution of ESAG families and both GARD and
PHI analyses have shown that most ESAG alignments contain
chimaeras (Figures 4 and S5, Table S1). In addition, localised
diversification has clearly occurred in some ESAG families such as
ESAG7 and 6, where the most diversifying codons can be mapped
to the exposed surface of the molecule, including the hypervariable
region. [11] (M. Carrington, University of Cambridge, personal
communication).
We also postulate that a by-product of the recombination
between ESAG families is the prevalence of some ESAGs as
apparent pseudogenes. Like VSGs, ESAG copies may be routinely
corrupted but continue to provide genetic resources for functional
copies, since they can be rescued by subsequent gene conversion
events. Whether ESAG evolution is adaptive, or simply a secondary
consequence of sharing the expression site environment, remains
to be seen.
The conclusion that both the whole BES and individual ESAGs
are mosaics raises the question as to how it is possible for two
contiguous markers, such as ESAG1 and 2, to display parallel
evolutionary histories, when both gene families are being
homogenised by frequent gene conversions. This should effectively
randomise the relationships of each ESAG family relative to each
other. Essentially, we could be observing recombination on two
different scales. Entire BESs recombine, perhaps as a secondary
effect of the VSG switching mechanism, but this is limited by
spatial proximity. At a finer scale, individual ESAGs recombine
with paralogs in other expression sites, which restrains the normal
process of divergence, tending to homogenise the entire family.
Our observation that BESs retain phylogenetic signals, i.e. a
pattern of divergence, demonstrates that substitutions affecting
ESAG sequences are not entirely homogenised by recombination.
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Therefore, for phylogenetic signals to persist, the substitution rate,
perhaps augmented by positive selection, must limit the extent of
homogenisation through recombination in a dynamic equilibrium.
Neighbouring ESAGs that are not separated by recombination
share this equilibrium and therefore, phylogenetic signal.
This work opens important perspectives in understanding the
molecular mechanisms of antigenic variation and telomere
biology. The fact that the short BES8 and BES10 could not be
activated in vitro opens the possibility of using these sites to identify
the minimum requirements to make a functional BES. The role of
telomeres in BES transcription has been extensively studied by
several groups (reviewed in [44]). Truncated BES may be a useful
tool to study telomere biology in T. brucei, since the distance
between the promoter and the telomere is much shorter. Finally,
BES sequences and overall architecture will aid the identification
of the mediators involved in VSG switching. Such studies may
reveal mechanisms that are relevant to telomere biology and
antigenic variation in other important pathogens.
Materials and Methods
Trypanosoma brucei
The BES TAR library was constructed from T. brucei Lister 427
strain clone 221a [45], in which a hygromycin-resistance gene had
been previously introduced immediately downstream of the
promoter of the active VSG221/427-2 expression site and a
neomycin-resistance gene downstream of the promoter of the
silent VSGVO2 expression site [22]. BES-tagged cell lines were
also derived from wild-type T. brucei 221a. Bloodstream-form
trypanosomes were grown in HMI-9 medium [46]. Stable
transfections were performed using the BTX Electroporator [47].
Isolation of TAR clones and preparation of sequencing
libraries
Yeast artificial chromosomes (YACs) containing BESs, TAR-
cloned using the conserved VSG BES promoter as a recombination
targets, have been previously described [19]. A representative clone
was chosen from each group, selecting a larger sized clone wherever
possible. Clones were isolated from yeast transformants through
separation of the YAC DNA from endogenous chromosomes by
CHEF (contour clamped homogeneous electric field) gel electro-
phoresis [48]. The recovered DNA was fragmented by sonication
and end-repaired with mung bean nuclease prior to preparative
agarose gel electrophoresis. DNA fragments of 2–4 kb and 1.4–2 kb
were purified and cloned into pUC18 plasmid vector.
Sequence determination, assembly and annotation
Nineteen TAR clones were sequenced by random sequencing of
small insert libraries using dye-terminator chemistry on an ABI
3730 sequencing machine. Sequence reads were assembled using
Phrap [www.phrap.org; P. Green, unpublished)]. Manual base
calling and finishing was carried out using Gap4 software (http://
www.mrc-lmb.cam.ac.uk/pubseq/manual/gap4_unix_1.html).
Gaps and low quality regions of the sequence were resolved by
primer walking and targeted polymerase chain reactions (PCR). A
number of gaps, all exclusively located in the 70-bp repeat regions,
remain in the assemblies and are indicated by 100 N’s (Figure 3).
Each clone was annotated using the Artemis software [49]. Protein
coding sequences were predicted as previously described and
analysed to assign putative functions as previously described [18].
The full annotation of 19 expression sites can be viewed and searched
via GeneDB (http://www.genedb.org/genedb/tbrucei427/) and
sequences have been submitted to EMBL with the following
accession numbers: FM162566 - FM162583.
Current VSG nomenclature reflects multiple naming schemes.
We therefore propose a new systematic nomenclature based on
sequential numbering with reference to the T. brucei Lister 427
strain (Table 1).
Sequence alignments
The Needle program, an implementation of Needleman-Wunsch
algorithm in the EMBOSS [50] software package was used to
perform global alignments using default parameters. The region of
the imperfect 70-bp repeats was excluded from each alignment.
Local alignments were performed using ClustalW (http://www.ebi.
ac.uk/clustalw/index.html) with default parameters
Generation of T. brucei clones with tagged BES
BES-tagged clones were generated by introducing a Puromycin
resistance gene (PUR) downstream of the promoter of a wild-type
VSG221/427-2 expressing cell line. NEO was subsequently
integrated downstream of the promoters of random BESs
conferring resistance to G418. Clones obtained from this
transfection were named BF-LF17.x or BF-LF18.x. depending
on the presence or absence of the 50-bp repeat array upstream of
BES1 promoter (Figueiredo et al., unpublished) (see also Data S1).
BES switching assay
To prevent premature growth of in situ switchers, NEO-tagged
clones were grown under Puromycin selection. After 5 days, cells
were subcloned by limiting dilution in the absence of any drug to
allow independent switching in each subclone. 2.46107 cells of 2–5
subclones were subsequently diluted in HMI-9 containing 100 mg/
mL G418, and distributed in a 24-well plate. After 6–8 days, the
number of G418-resistant clones was counted. Switching frequency
was calculated by dividing the number of G418-resistant clones by
the total number of plated cells. One or two clones from each plate
were tested for Puromycin sensitivity by diluting 105 cells in 5 mL of
HMI-9 containing Puromycin at 1 mg/mL. Cell growth was scored
after 2 days. Western Blotting was performed to confirm that G418-
resistant cells no longer expressed VSG221/427-2.
Cloning the ESAG6 hypervariable region
The ESAG6 hypervariable region of each NEO-tagged BES was
PCR amplified using a NEO-specific primer and one of two
ESAG6-specific primers (59-TAAAGAGAGTTGTTCACTCAC-
39 or 59-TGTTCACTCACTCTCTTTGAC-39) and the products
gel-purified and sequenced. From clones with two consecutive
ESAG6 genes, the ESAG6 hypervariable region from the most
telomeric ESAG6 gene, was reamplified from the largest PCR
fragment by nested-PCR with primers: 59-CACTAATGAT-
CAGCTTTACG-39 and 59-GACTCTTTTACACGTGAATC-
39. The resulting 1-kb fragment was purified and sequenced.
Cloning the expressed VSG
Total RNA was extracted from ,108 G418-resistant cells with
RNA STAT-60 reagent (TEL-TEST, Inc.), following the
manufacturer’s instructions. cDNA was synthesized using a
PolyT-primer and the StrataScriptTM First Strand Synthesis
System (Stratagene). VSG cDNA was amplified with primers that
bind to the spliced leader (59-GACTAGTTTCTGTACTATAT-
39) and to a conserved sequence found in the 39UTR of all VSG
(59-GTGTTAAAATATATC-39). Using the spliced leader primer
ensured that the amplified product originated only from trans-
spliced RNA and not from a DNA contaminant. PCR products
were subsequently cloned in pGEM-T Easy (Promega) and
sequenced.
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Chromosome separation by CHEF
T. brucei chromosomes were separated using a CHEF electro-
phoresis apparatus (CHEF-DR III, Bio-Rad), loading DNA from
approximately 26107 cells per lane. Electrophoresis conditions for
the panel separating T. brucei intermediate chromosomes were:
25 s pulse time, 6 V/cm, for 20 h, in 0.56TBE, at 14uC, using a
gel of 1% high-strength agarose (Helena Biosciences). T. brucei
megabase chromosomes were separated using 1400–700 s linear
ramped pulse, 2.5 V/cm, for 144 h in 16TBE at 14uC in a gel
with 1.2% high-strength agarose.
Long-range Southern blotting
Agarose-embedded chromosome plugs were digested with 40 units
of Apa I or Apa I and Xma I (New England Biolabs), as previously
described [51]. Restriction products were separated on a 1.0%
agarose gel in 0.56Tris-Borate-EDTA buffer (TBE) in the Stratagene
Rotating Agarose Gel Electrophoresis variant of Pulsed Field Gel
Electrophoresis (PFGE) at 12uC and with a rotation angle of 120u.
The running program for Apa I restriction fragments consisted of a 5
to 15 sec linear ramp at a constant 155 V for 18 h. For Apa I andXma
I restriction fragments the program was 1 to 4 sec linear ramp at a
constant 150 V for 18 h. After alkaline transfer and hybridization
with a radioactive probe, the Hybond-N+ Nylon membranes
(Amersham Biosciences) were typically washed at 65uC as follows:
twice for 20 min with 26Sodium Chloride/Sodium Citrate (SSC),
0.1% SDS and twice for 20 min with 0.56SSC, 0.1%SDS.
Comparison of phylogenetic signal among ESAGs
ClustalX was used to align homologs of 7 ESAG loci from 11
different expression sites [52]. The maximum likelihood phyloge-
netic tree topology was estimated for each locus using the program
PHYML [53], with a GTR+C model and parameters estimated
from the data. By constraining the resulting trees with the optimal
topology of each other locus in turn a further six tree topologies were
produced for each locus. The differences in likelihood value between
the optimal tree and each constrained tree were calculated and the
significance evaluated using the Shimodaira-Hasegawa test [54] thus
quantifying the difference in phylogenetic signal between different
loci along the expression site. Such likelihood comparisons require
that two trees have equal taxon sets. For this reason a consistent gene
complement from each expression site was used and ESAG10 and
ESAG7 were therefore excluded. ESAG3 was also not used because it
is present in three positions along the expression site and does not
cluster by position; hence, its phylogenetic signal was not amenable
to positional comparisons.
Characterization of recombination
Sequence alignments of each ESAG family and selected
intergenic regions were generated with ClustalX as described
above, manually edited and gap-stripped. Each alignment was
tested for evidence of recombination using two approaches. (i) The
likelihood-based method implemented in the program GARD
([31]; http://www.datamonkey.org/GARD) was used to identify
putative recombination and gene conversion breakpoints, em-
ploying a nucleotide substitution model specified by the HyPhy
software package ([55]; http://www.hyphy.org). (ii) The program
Phi [32]; http://www.mcb.mcgill.ca/,trevor) was used to assess
the significance of the pairwise homoplasy index (Ww) with a
window size of 100 bases and 10,000 permutations per test.
Adaptive evolution of ESAG sequences
ESAG protein-coding sequences were analysed for adaptive
evolution by estimating the relative rates of non-synonymous and
synonymous substitutions within each ESAG family. Positive
selection is indicated by a non-synonymous/synonymous rate ratio
(v) greater than 1. The method was modified for recombinant
sequences by allowing the genealogy to vary across the alignment
while sharing the parameters of the codon substitution model
between tracts [56]. The dimensions and genealogies of putative
recombination tracts were provided by the GARD analyses
described previously. HyPhy was used to obtain maximum
likelihood estimates for two nested models of the distribution of
v. A likelihood ratio test for positive selection was performed with
a x2-distribution on two degrees of freedom by comparing twice
the log-likelihood difference between a nearly-neutral model (M1a,
in which v cannot exceed 1) and a selection model (M2a) that
included an additional category for v.1 [57]. Evidence for
adaptive evolution at individual codons was tested using an
empirical Bayes method [57]: model M2a, with the maximum
likelihood estimated parameters, was taken as a prior distribution
for v, and Bayes’ formula was used to calculate the posterior
distribution of v at each codon, given the sequence data.
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